Printer Friendly
The Free Library
21,610,989 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CEO INTERVIEW: STEPHEN DAVIS - NEUROGEN CORPORATION (NRGN).

(NAH329) STEPHEN DAVIS Davis, city (1990 pop. 46,209), Yolo co., central Calif.; settled in the 1850s, inc. 1917. It is an education center with light industry; machinery, processed foods, and computer equipment are produced. The extensive Univ.  - NEUROGEN CORPORATION (NRGN NRGN Neurogen Corporation (Branford, Connecticut) ). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Biotechnology. Published date 10/12/01. Tickers featured: NRGN. Complete text approximately 3000 words. Document # NAH329.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript A generic term for any kind of copy, particularly an official or certified representation of the record of what took place in a court during a trial or other legal proceeding.

A transcript of record
, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2001 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:CEO INTERVIEW: STEPHEN DAVIS - NEUROGEN CORPORATION (NRGN).
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Oct 9, 2001
Words:88
Previous Article:CEO INTERVIEW: MICHELE GARUFI - NICOX S.A.
Next Article:CEO INTERVIEW: PAUL FREIMAN - NEUROBIOLOGICAL TECHNOLOGIES INC (NTII).
Topics:



Related Articles
Neurogen announces new licensing agreement with Pfizer's Animal Health division
HARRY PENNER JR. - NEUROGEN CORPORATION (NRGN).
STEPHEN DAVIS - NEUROGEN CORPORATION (NRGN).
Neurogen and Aventis PHARMA announce worldwide collaboration.
CEO INTERVIEW: RAYMOND DAVIS - UMPQUA HOLDINGS CORPORATION.
CEO INTERVIEW: WILLIAM KOSTER - NEUROGEN CORPORATION (NRGN).
Neurogen, Merck agreement for pain drugs cleared.
CEO INTERVIEW: WILLIAM KOSTER - NEUROGEN CORPORATION (NRGN).
New genes' discovery confirms immune system may play a role in schizophrenia.

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles